United States · FDA National Drug Code directory

Relaxoforce

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
43857-0545_a57d489a-e899-49a0-a47a-c8a134322b2a
Product NDC
43857-0545
Form
LIQUID
Composition / generic term
Humulus Lupulus, Passiflora Incarnata, Valeriana Officinalis, Calcarea Carbonica, Coffea Tosta, Ignatia Amara, Kali Phosphoricum, Moschus, Nux Vomica, Phosphorus, Pulsatilla (Pratensis)
Labeler
BioActive Nutritional, Inc.
Marketing category
UNAPPROVED HOMEOPATHIC
Marketing start / end (source format)
20200219
Source listing expiry
20271231

Source-listed ingredients

  • HOPS — 3 [hp_X]/mL
  • PASSIFLORA INCARNATA FLOWERING TOP — 3 [hp_X]/mL
  • VALERIAN — 3 [hp_X]/mL
  • OYSTER SHELL CALCIUM CARBONATE, CRUDE — 12 [hp_X]/mL
  • COFFEA ARABICA SEED, ROASTED — 12 [hp_X]/mL
  • STRYCHNOS IGNATII SEED — 12 [hp_X]/mL
  • DIBASIC POTASSIUM PHOSPHATE — 12 [hp_X]/mL
  • MOSCHUS MOSCHIFERUS MUSK SAC RESIN — 12 [hp_X]/mL
  • STRYCHNOS NUX-VOMICA SEED — 12 [hp_X]/mL
  • PHOSPHORUS — 12 [hp_X]/mL
  • PULSATILLA PRATENSIS WHOLE — 12 [hp_X]/mL

These values do not establish equivalence or a dose recommendation.

Packages

  • 30 mL in 1 BOTTLE, DROPPER (43857-0545-1) · 43857-0545-1

Source and coverage

Open FDA National Drug Code directory

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →
Relaxoforce — United States | Molindra Medicines